3-(CHLOROMETHYL)-5-(1,2,3-THIADIAZOL-4-YL)-1,2,4-OXADIAZOLE
|
- $110 - $364
- Product name: 3-(CHLOROMETHYL)-5-(1,2,3-THIADIAZOL-4-YL)-1,2,4-OXADIAZOLE
- CAS: 253586-59-3
- MF: C5H3ClN4OS
- MW: 202.62
- EINECS:
- MDL Number:MFCD01313801
- Synonyms:BUTTPARK 154\06-80;3-(CHLOROMETHYL)-5-(1,2,3-THIADIAZOL-4-YL)-1,2,4-OXADIAZOLE;4-[3-(Chloromethyl)-1,2,4-oxadiazol-5-yl]-1,2,3-thiadiazole;3-(chloromethyl)-5-(thiadiazol-4-yl)-1,2,4-oxadiazole;1,2,4-Oxadiazole, 3-(chloromethyl)-5-(1,2,3-thiadiazol-4-yl)-
3 prices
Selected condition：
Brand
- Crysdot
- SynQuest Laboratories
- TRC
Package
- 100mg
- 1g
- ManufacturerCrysdot
- Product numberCD11158407
- Product description3-(Chloromethyl)-5-(1,2,3-thiadiazol-4-yl)-1,2,4-oxadiazole 97%
- Packaging1g
- Price$364
- Updated2021-12-16
- Buy
- ManufacturerSynQuest Laboratories
- Product number8H70-5-W2
- Product description3-(Chloromethyl)-5-(1,2,3-thiadiazol-4-yl)-1,2,4-oxadiazole
- Packaging1g
- Price$170
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberC385483
- Product description3-(Chloromethyl)-5-(1,2,3-thiadiazol-4-yl)-1,2,4-oxadiazole
- Packaging100mg
- Price$110
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Crysdot | CD11158407 | 3-(Chloromethyl)-5-(1,2,3-thiadiazol-4-yl)-1,2,4-oxadiazole 97% | 1g | $364 | 2021-12-16 | Buy |
| SynQuest Laboratories | 8H70-5-W2 | 3-(Chloromethyl)-5-(1,2,3-thiadiazol-4-yl)-1,2,4-oxadiazole | 1g | $170 | 2021-12-16 | Buy |
| TRC | C385483 | 3-(Chloromethyl)-5-(1,2,3-thiadiazol-4-yl)-1,2,4-oxadiazole | 100mg | $110 | 2021-12-16 | Buy |
Properties
Boiling point :363.0±52.0 °C(Predicted)
Density :1.588±0.06 g/cm3(Predicted)
pka :-6.37±0.43(Predicted)
Density :1.588±0.06 g/cm3(Predicted)
pka :-6.37±0.43(Predicted)
Safety Information
| Symbol(GHS): |
|
||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal word: | Warning | ||||||||||||||||||||||||||||
| Hazard statements: |
|
||||||||||||||||||||||||||||
| Precautionary statements: |
|